About Infigo Eyecare
Infigo Eyecare is a company based in Mumbai (India) founded in 2018 by Anil Kamath and Shridhar Thakur was acquired by IIFL Finance in June 2019. Infigo Eyecare has raised $5.83 million across 1 funding round from investors including IIFL Finance and 360 One. The company has 98 employees as of April 07, 2024. Infigo Eyecare offers products and services including Cataract Surgery, Glaucoma Treatment, Diabetic Retinopathy Care, and Retinal Examination. Infigo Eyecare operates in a competitive market with competitors including Ramkrishna Netralaya, Dekhon, Swaraashi Netralaya, Trinity Optics and Eye Health Clinic, among others.
- Headquarter Mumbai, India
- Employees 98 as on 07 Apr, 2024
- Founders Anil Kamath, Shridhar Thakur
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Infigo Lifesciences Private Limited
- Date of Incorporation 26 Sep, 2017
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$2.09 M (USD)20.36as on Mar 31, 2023
-
Net Profit
-$469.41 K (USD)-241.61as on Mar 31, 2023
-
EBITDA
-$346.33 K (USD)-87.87as on Mar 31, 2023
-
Total Equity Funding
$5.83 M (USD)
in 1 rounds
-
Latest Funding Round
$5.83 M (USD), Series A
Aug 07, 2018
-
Investors
IIFL Finance
& 1 more
-
Employee Count
98
as on Apr 07, 2024
-
Acquired by
IIFL Finance
(Jun 23, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Infigo Eyecare
Infigo Eyecare offers a comprehensive portfolio of products and services, including Cataract Surgery, Glaucoma Treatment, Diabetic Retinopathy Care, and Retinal Examination.
Procedure to remove cloudy lens for improved vision clarity.
Therapies to control eye pressure and prevent vision loss.
Treatments for diabetes-related eye damage to maintain sight.
Comprehensive tests to detect and monitor retinal conditions.
Funding Insights of Infigo Eyecare
Infigo Eyecare has successfully raised a total of $5.83M through 1 strategic funding round. The most recent funding activity was a Series A round of $5.83 million completed in August 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Infigo Eyecare
Infigo Eyecare has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include IIFL Finance and 360 One.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Asset and wealth management software is provided for businesses.
|
Locked | Locked | Locked | |
|
Online gold, home, personal, and business loans are provided.
|
Locked | Locked | Locked |
Investor details for Infigo Eyecare
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Infigo Eyecare
Investment portfolio details for Infigo Eyecare
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Infigo Eyecare
Detailed financials for Infigo Eyecare
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Infigo Eyecare Comparisons
Peer comparison for Infigo Eyecare
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Infigo Eyecare
Infigo Eyecare operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ramkrishna Netralaya, Dekhon, Swaraashi Netralaya, Trinity Optics and Eye Health Clinic, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Offers specialized eye surgeries for cataract, glaucoma, and vision correction.
|
|
| Locked | Locked | Locked |
Offers eye care services, outreach, and donations to communities in India.
|
|
| Locked | Locked | Locked |
Operates a chain of eye care clinics providing specialized medical services.
|
|
| Locked | Locked | Locked |
Operates a chain of eye care clinics providing comprehensive services.
|
|
| Locked | Locked | Locked |
Provides eye treatments for cataract, LASIK, glaucoma, and vision syndrome in multiple locations.
|
Detailed competitors of Infigo Eyecare
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Infigo Eyecare
Complete news archive for Infigo Eyecare
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Infigo Eyecare
Infigo Eyecare was founded in 2018.
Infigo Eyecare is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Shridhar Thakur is the current CEO of Infigo Eyecare. They have also founded this company.
Infigo Eyecare is a funded company, having raised a total of $5.83M across 1 funding round to date.
As of Apr 07, 2024, the latest employee count at Infigo Eyecare is 98.
Annual revenue of Infigo Eyecare is $2.09M as on Mar 31, 2023.
Infigo Eyecare was established in 2018 in Mumbai, India, as a chain of eye care clinics. Operations are centered on delivering eye care services within the healthcare sector. The company is led by co-founders Anil Kamath and Shridhar Thakur, with Thakur designated as CEO. Its online presence is maintained via the domain infigoeye.com, supporting clinic activities in the region.
Infigo Eyecare's top competitors include Ramkrishna Netralaya, Dekhon and Swaraashi Netralaya.
Infigo Eyecare offers Cataract Surgery, Glaucoma Treatment, Diabetic Retinopathy Care, and Retinal Examination.
Infigo Eyecare has 2 investors. Key investors include IIFL Finance, and 360 One.